Dr. Christian Ruff, MD

• Cardiology

• Internal Medicine

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• Brigham And Womens Hospital

  Fellowship Hospital, 2010

• Brigham And Womens Hospital

  Residency Hospital, 2006

• Brigham And Womens Hospital

  Internship Hospital, 2004

• Johns Hopkins School Of Medicine

  Medical School, 2003

• The prognostic significance of cardiac structure and function in atrial fibrillation: the ENGAGE AF-TIMI 48 Echocardiographic Substudy, 2016-04-20

• Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries, 2022-11-14

• Direct Oral Anticoagulants versus Warfarin in Patients with Atrial Fibrillation: Patient-Level Network Meta-Analyses of Randomized Clinical Trials with Interaction Testing by Age and Sex, 2022-01-05

• Performance of the ABC Scores for Assessing the Risk of Stroke or Systemic Embolism and Bleeding in Patients with Atrial Fibrillation in ENGAGE AF-TIMI 48, 2019-02-05

• Evaluating the effects of socioeconomic status on stroke and bleeding risk scores and clinical events in patients on oral anticoagulant for new onset atrial fibrillation, 2021-03-18

• Publisher Correction: Endophenotype effect sizes support variant pathogenicity in monogenic disease susceptibility genes, 2022-09-30

• Genetic Risk Score to Identify Risk of Venous Thromboembolism in Patients with Cardiometabolic Disease, 2021-01-12

• Diagnostic evaluation of the MRP-8/14 for the emergency assessment of chest pain, 2014-06-05

• The Effect of PCSK9 Inhibition on the Risk of Venous Thromboembolism, 2020-03-29

• Re-adjudication of the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS) with study-level meta-analysis of hospitalization for heart failure from cardiovascular outcomes trials with dipeptidyl peptidase-4 (DPP-4) inhibitors, 2022-06-17

• Endophenotype effect sizes support variant pathogenicity in monogenic disease susceptibility genes, 2022-08-30

• Discovery and systematic characterization of risk variants and genes for coronary artery disease in over a million participants, 2022-12-06

• Personalized Anticoagulation: Optimizing Warfarin Management Using Genetics and Simulated Clinical Trials, 2017-11-04

• No association betweenAPOEgenotype and lipid lowering with cognitive function in a randomized controlled trial of evolocumab, 2022-04-11

• Left atrial structure and function and the risk of death or heart failure in atrial fibrillation, 2019-11-27

• Clinical Application of a Novel Genetic Risk Score for Ischemic Stroke in Patients with Cardiometabolic Disease, 2020-11-13

• Stroke genetics informs drug discovery and risk prediction across ancestries, 2022-09-30

• Comparison of the Efficacy and Safety Outcomes of Edoxaban in 8040 Women Versus 13 065 Men With Atrial Fibrillation in the ENGAGE AF-TIMI 48 Trial, 2021-02-16

• Reversal Agents: What We Have and What We Can Expect, 2018-04-15

• A Targeted Proteomic Approach Identifies Novel Biomarkers of Arterial Thromboembolic Risk in ENGAGE AF-TIMI 48, 2021-08-10

• The Effect of PCSK9 (Proprotein Convertase Subtilisin/Kexin Type 9) Inhibition on the Risk of Venous Thromboembolism, 2020-10-26